Chang Yeop Han Selected Research

Enzymes

3/2005

Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chang Yeop Han Research Topics

Disease

15	Inflammation (Inflammations) 01/2023 - 03/2005
7	Obesity 01/2020 - 09/2007
5	Insulin Resistance 03/2017 - 04/2008
3	Hemorrhage 10/2023 - 01/2022
3	Atherosclerosis 11/2012 - 03/2005
2	Weight Gain 11/2012 - 04/2008
1	Multiple Trauma (Multiple Injuries) 10/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Hemorrhagic Shock 01/2023
1	Tics (Tic) 01/2023
1	Critical Illness (Critically Ill) 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2020
1	Dyslipidemias (Dyslipidemia) 11/2012
1	Hyperlipidemias (Hyperlipidemia) 07/2009
1	Hypertrophy 09/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2005
1	Vascular Diseases (Vascular Disease) 03/2005

Drug/Important Bio-Agent (IBA)

5	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2020 - 03/2005
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 03/2012
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2005
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 12/2020 - 03/2005
3	CholesterolIBA 12/2020 - 11/2012
3	PalmitatesIBA 12/2020 - 01/2016
3	Proteoglycans (Proteoglycan)IBA 01/2020 - 01/2016
2	Superoxides (Superoxide)IBA 01/2023 - 01/2022
2	Fibrinogen (Factor I)FDA Link 01/2023 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2017 - 08/2016
2	Sucrose (Saccharose)IBA 03/2017 - 11/2012
2	Nonesterified Fatty Acids (NEFA)IBA 08/2016 - 03/2012
2	Dietary CholesterolIBA 11/2012 - 04/2008
2	LDL Receptors (LDL Receptor)IBA 11/2012 - 04/2008
2	Lipoproteins (Lipoprotein)IBA 11/2012 - 03/2005
2	Aryldialkylphosphatase (Paraoxonase)IBA 08/2006 - 03/2005
1	AntioxidantsIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	CytokinesIBA 01/2023
1	ChemokinesIBA 01/2023
1	MelanocortinsIBA 01/2023
1	LipopolysaccharidesIBA 01/2022
1	Conditioned Culture MediaIBA 01/2020
1	BiglycanIBA 01/2020
1	Versicans (Versican)IBA 01/2020
1	NADPH Oxidase 4IBA 03/2017
1	CarbohydratesIBA 11/2012
1	LipidsIBA 11/2012
1	Ezetimibe (Zetia)FDA Link 11/2012
1	Protein Isoforms (Isoforms)IBA 07/2009
1	Messenger RNA (mRNA)IBA 07/2009
1	Apolipoproteins E (ApoE)IBA 07/2009
1	Amyloid (Amyloid Fibrils)IBA 04/2008
1	Blood Proteins (Serum Proteins)IBA 04/2008
1	Hyaluronan SynthasesIBA 09/2007
1	Hyaluronic Acid (Hyaluronan)IBA 09/2007
1	EnzymesIBA 03/2005
1	Phospholipases (Phospholipase)IBA 03/2005
1	Platelet Activating FactorIBA 03/2005
1	C-Reactive ProteinIBA 03/2005
1	ApolipoproteinsIBA 03/2005
1	low density lipoprotein inhibitorIBA 03/2005
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2005
1	Peroxidase (Myeloperoxidase)IBA 03/2005

Therapy/Procedure

1	Resuscitation 10/2023
1	Intravenous Infusions 10/2023
1	Glycemic Control 12/2020
1	Therapeutics 03/2017